Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Maeva Dufies | M | - |
Roca Therapeutics SAS
 Roca Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Roca Therapeutics SAS is a French company that engages in research and drug development in the fields of oncology, ophthalmology, and immunology. The company is based in Nice, France. The company was founded in 2021. The CEO is Maeva Dufies. | - |
| Isabelle de Cremoux | F | 54 |
Iome Bio SA
 Iome Bio SA Pharmaceuticals: OtherHealth Technology Iome Bio SA is a French company that provides drug discovery services using microbiome based mechanisms. The company is based in Colmar, France. Katharine Holland has been the CEO of the company since 2021. | - |
| Roberto de Ponti | M | - |
Roca Therapeutics SAS
Roca Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Roca Therapeutics SAS is a French company that engages in research and drug development in the fields of oncology, ophthalmology, and immunology. The company is based in Nice, France. The company was founded in 2021. The CEO is Maeva Dufies. | - |
| Zafrira Avnur | F | - |
Iome Bio SA
Iome Bio SA Pharmaceuticals: OtherHealth Technology Iome Bio SA is a French company that provides drug discovery services using microbiome based mechanisms. The company is based in Colmar, France. Katharine Holland has been the CEO of the company since 2021. | 4 ans |
| Katharine Holland | F | - |
Iome Bio SA
Iome Bio SA Pharmaceuticals: OtherHealth Technology Iome Bio SA is a French company that provides drug discovery services using microbiome based mechanisms. The company is based in Colmar, France. Katharine Holland has been the CEO of the company since 2021. | 3 ans |
| Eric Rambeaux | M | - |
Iome Bio SA
Iome Bio SA Pharmaceuticals: OtherHealth Technology Iome Bio SA is a French company that provides drug discovery services using microbiome based mechanisms. The company is based in Colmar, France. Katharine Holland has been the CEO of the company since 2021. | 2 ans |
| Abdijapar Shamshiev | M | - |
Iome Bio SA
Iome Bio SA Pharmaceuticals: OtherHealth Technology Iome Bio SA is a French company that provides drug discovery services using microbiome based mechanisms. The company is based in Colmar, France. Katharine Holland has been the CEO of the company since 2021. | 2 ans |
| Kaley Wilson | M | - |
Iome Bio SA
Iome Bio SA Pharmaceuticals: OtherHealth Technology Iome Bio SA is a French company that provides drug discovery services using microbiome based mechanisms. The company is based in Colmar, France. Katharine Holland has been the CEO of the company since 2021. | 2 ans |
| Rachid Benhida | M | - |
Roca Therapeutics SAS
Roca Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Roca Therapeutics SAS is a French company that engages in research and drug development in the fields of oncology, ophthalmology, and immunology. The company is based in Nice, France. The company was founded in 2021. The CEO is Maeva Dufies. | - |
| Cyril Ronco | M | - |
Roca Therapeutics SAS
Roca Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Roca Therapeutics SAS is a French company that engages in research and drug development in the fields of oncology, ophthalmology, and immunology. The company is based in Nice, France. The company was founded in 2021. The CEO is Maeva Dufies. | - |
| Gilles Pagès | M | - |
Roca Therapeutics SAS
Roca Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Roca Therapeutics SAS is a French company that engages in research and drug development in the fields of oncology, ophthalmology, and immunology. The company is based in Nice, France. The company was founded in 2021. The CEO is Maeva Dufies. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| France | 11 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Zaki Sellam
- Réseau Personnel
